glp‑1
Yes, prescription GLP-1 weight-loss drugs can improve kidney outcomes in type 2 diabetes. A 2023 clinical trial showed semaglutide cut urinary albumin excretion by 20% in just 12 weeks, a change tied to slower progression of diabetic kidney disease. Medical Disclaimer: This article is for informational purposes only and does
glp‑1
Save $30 Billion With Prescription Weight Loss? Prescription weight-loss drugs could shave roughly $30 billion from the U.S. health-care bill by curbing obesity-related costs. The surge in GLP-1 usage is reshaping how insurers and policymakers budget for chronic disease treatment. Medical Disclaimer: This article is for informational purposes only
glp‑1
Stop Losing Control With Secret Obesity Treatment For Alcoholics GLP-1 therapy can dramatically reduce heavy-drinking days while promoting weight loss in people who struggle with obesity and alcohol use disorder. In clinical practice the dual benefit reshapes how we approach two intertwined conditions. In a single-center study, patients receiving a